Lombard Medical Technologies Share Discussion Threads

[nod] 21/6/2013 11:24

All looking positive albeit a bit slower than I would like.We now have date for the US launch - "a coordinated launch event will take place at the VEITH symposium in New York City in November 2013."

[philo124] 21/6/2013 08:39

Yes, in time.

[rayrac] 21/6/2013 08:09

How long will LMT remain as is now!

I added 5k this am, hoping we can reach a new high on the chart...it looks possible.

[skinny] 14/6/2013 06:05

London, UK, 14 June 2013 - Lombard Medical Technologies PLC (AIM:LMT), the specialist medical technology company focussed on innovative vascular products, announces that it has yesterday, under the Company's Share Option Plan (2005), granted 3,209,394 new share options over ordinary shares of 20p each in the Company, at an exercise price of 177.5 pence per share, to its Directors and employees. Following this grant, there will be 5,342,607 share options in issue, representing 11.9% of the Company's issued shares, calculated including the shares to be issued following the Placing, Subscription and Offer and conversion of Convertible Loan Notes announced on 24 May 2013; the share options in issue to the Directors will represent 7.4% of this issued shares figure.

[skinny] 13/6/2013 07:27

London, UK, 13 June 2013 - On 24 May 2013, Lombard Medical Technologies PLC (AIM:LMT) announced an issue of equity to raise GBP21.0 million (before expenses) by way of a Placing and Subscription. In conjunction with the Placing and Subscription, the Board also announced details of an Offer to Qualifying Participants to raise up to an additional GBP2.0 million (before expenses). The Board also announced that the Convertible Loan Notes issued to Invesco Asset Management Limited would be converted into ordinary shares.

The Company is pleased to announce that, at the close of the Offer at 11.00 a.m. on 12 June 2013, Qualifying Participants had conditionally applied for 398,518 New Ordinary Shares at a price of 175 pence per New Ordinary Share, raising an additional GBP0.7 million (before expenses).

Application has been made for 14,541,375 New Ordinary Shares, being the total number of New Ordinary Shares being issued under the Placing and Subscription, the Offer and the conversion of the Convertible Loan Notes, to be admitted to trading on AIM. Subject to and conditional upon the passing of the Resolutions at the forthcoming General Meeting, admission is expected to become effective on 17 June 2013.

[multiplural] 10/6/2013 15:00

This stock is some sort of scam. I know that someone is trying to sell 50k at a limit of 1,75. Yet the marketmakers show 179 bid, and the guy in question have sold zero.

[stable] 07/6/2013 08:14

Investors Chronicle yesterday, LMT a buy, does a lot of good I notice this morning.

[skinny] 06/6/2013 14:47

Just had my email.

"Option 2 – You can purchase new Shares. The terms of the Offer allow you to buy new Shares at £1.75 each (a maximum of 1,142,857 Shares are available under the Offer). Applications may be scaled back at the directors discretion if applications are received for more Shares than the Offer allows.

Any instruction to purchase new Shares must be received by our deadline of noon on Tuesday 11 June 2012."

[rayrac] 25/5/2013 22:00

It's a buy multi!

[callumross] 24/5/2013 19:28

Are you for real, multiplural. What a load of gash.

[multiplural] 24/5/2013 14:52

I hate to be right . See my post 1661 from two days ago. They are exactly doing what I feared. Imo it is criminal to issue at this price if they have a bid for the company at much higher levels

[rayrac] 24/5/2013 12:37

Shame about ordinary shareholders not getting a piece of the pie. Or am I reading this wrong?

Very much worth holding the shares though!

[skinny] 24/5/2013 12:24

London, UK, 24 May 2013 - Lombard Medical Technologies PLC (AIM: LMT), the specialist medical technology company focussed on innovative vascular products, today announces that it proposes to raise £21.0 million (before expenses) through a Placing and Subscription, arranged on the Company's behalf by Canaccord Genuity Limited and WG Partners, a trading name of Charles Stanley & Co. Ltd. The Issue Price of 175 pence per Ordinary Share represents a discount of 5 per cent. to the closing middle market price of 184.5 pence per existing Ordinary Share on 23 May 2013 (being the last practicable date prior to the date of this announcement). In conjunction with the Placing and Subscription, Qualifying Participants are being invited to participate in the Fundraising pursuant to an Offer that may raise up to an additional £2.0 million (before expenses).

The Company expects to use the net proceeds of the Placing and Subscription of £20 million, together with Lombard Medical's existing cash resources of £15.2 million, approximately as follows:

• Build sales and marketing infrastructure ahead of U.S. commercial launch in the second half of 2013 (10%)
• Post U.S. launch continue to grow AorfixTM market share in the U.S. (35%)
• Expand AorfixTMproduction capacity (17%)
• Develop next generation products, line extensions and delivery devices (17%)
• Clinical trials (10%)
• Grow rest of world sales of AorfixTM and launch in select new territories (including Japan in 2014) (11%)

The Directors currently anticipate that the proceeds of this proposed Placing and Subscription will enable the Company to achieve its longer-term goals in the U.S. market and to support Lombard Medical's strategy through to cash generation.

[nod] 22/5/2013 12:13

There doesn't appear to be an analyst presentation or anything upbeat. I suppose it will be just a show of hands to pass the pre-agreed resolutions.

[nod] 22/5/2013 12:08

AGM is tomorrow.

[stable] 22/5/2013 09:08

agm shortly, let us see what they have to say, if anything

[multiplural] 22/5/2013 08:06

I have a feeling that the large owners are keeping the price down . The purpose is to issue even more equity and thus dilute us smaller shareholders further before the final sale. Imo they could easily sell the company as is for 350-400p , but as always these kinds are greedy and will dilute us first. What do others think?

[nod] 10/5/2013 10:18

I was just going to write there was no reaction from any shareholders on the patent news when there was suddenly a massive fall in the share price on 2k of sells.Well, maybe not massive but a few trades.It indicates that all the major shareholders were fully aware of this patent issue and had been for a very long time otherwise we would have seen action earlier. Not to dismiss it glibly it may be worth looking back at major shareholder changes and asking if it may have been influenced by the Medtronic move.It would have likely been flagged several months ago with a letter from Medtronic demanding licence fees.

[nod] 08/5/2013 10:02

I'm in New Zealand :)

[glasswala] 08/5/2013 06:24

Could not sleep ah Nod!! This is aim market for you!!

[nod] 08/5/2013 03:11

Lombard Medical Technologies PLC (LON: LMT)'s stock had its "buy" rating reiterated by equities research analysts at Panmure Gordon in a research note issued to investors on Tuesday, Stock Ratings Network reports. They currently have a GBX 321 ($5.00) price target on the stock.Separately, analysts at Canaccord Genuity reiterated a "buy" rating on shares of Lombard Medical Technologies PLC in a research note to investors on Friday, March 22nd. They now have a GBX 326.88 ($5.09) price target on the stock.Lombard Medical Technologies PLC (LON: LMT) opened at 203.95 on Tuesday. Lombard Medical Technologies PLC has a 52-week low of GBX 52.00 and a 52-week high of GBX 250.00. The stock's 50-day moving average is currently GBX 108.8.http://zolmax.com/lombard-medical-technologies-plc-receives-buy-rating-from-panmure-gordon-lmt/63214/

[nod] 07/5/2013 23:03

Our CEO used to work for Medtronic.A few years ago LMT had an exclusive licensing agreement with Medtronic for RefixTM which Medtronic sold as Securant under a "collaboration agreement" with LMT.